New COVID Variant ‘NB.1.8.1’ Sparks Global Concern — UK Cases Rising
Glasgow, Scotland – June 11, 2025 - A newly identified COVID-19 subvariant, NB.1.8.1—unofficially dubbed "Nimbus"—is rapidly spreading across multiple countries, including the UK, sparking renewed concern among public health officials.
The variant, a descendant of the Omicron lineage, now accounts for over 10% of global cases, according to the World Health Organization (WHO). First detected in early 2025, NB.1.8.1 has been reported in more than 20 nations, including the United States, China, India, and Australia. In the UK, cases have notably increased in recent weeks, particularly in England and Scotland.
Mild Symptoms, but Widespread Transmission
Medical experts say that although Nimbus is not linked to increased severity, it does show signs of being more transmissible than previous Omicron strains. Most individuals infected with NB.1.8.1 have reported sore throats, fatigue, nasal congestion, and mild fever. However, a spike in gastrointestinal symptoms—such as nausea, diarrhoea, and stomach discomfort—has also been observed.
“There is no evidence so far that this variant leads to more hospitalisations or deaths,” said Dr. Maria Van Kerkhove, WHO’s COVID-19 Technical Lead. “But with fewer people testing regularly, we risk underestimating its spread.”
WHO Designation: “Variant Under Monitoring”
The WHO has officially designated NB.1.8.1 as a "Variant Under Monitoring", indicating that it does not currently pose a major threat but requires close observation due to its mutation profile. Scientists note that changes in the spike protein may allow the virus to bind more easily to human cells, potentially increasing infection rates.
UK Health Response and Public Guidance
The UK Health Security Agency (UKHSA) has urged the public to remain cautious, especially those with underlying health conditions. The government has not reintroduced any restrictions but advises the public to test when symptomatic, stay home if unwell, and keep up with vaccine boosters.
Schools, hospitals, and care homes have been issued updated guidance to reinforce hygiene measures and ventilation protocols. Pharmacies are also reporting a rise in demand for lateral flow tests.
Scientists Urge Continued Vigilance
Although the current risk remains low, virologists warn that reduced global surveillance makes it harder to track future mutations. They recommend continued investment in genomic sequencing and vaccine adaptability.
“COVID isn’t gone—it’s evolving,” said Professor Lawrence Young, virologist at the University of Warwick. “This is a timely reminder that we must keep our guard up.”
What You Can Do
Stay home if you feel unwell
Use lateral flow tests when showing symptoms
Update your vaccine booster if eligible
Avoid close contact with vulnerable individuals
Practice good ventilation and hygiene
As summer travel increases, experts also warn holidaymakers to check destination-specific health guidelines.
Stay informed. Stay protected.
For updates, follow UKHSA.gov.uk.